NEW YORK, May 22, 2013 /PRNewswire/ --
Lifshitz Law Firm announces that it is investigating potential claims against the board of Chemed Corporation ("Chemed" or the "Company") (CHE). On May 2, 2013, the government filed a False Claims Act complaint against the Company and certain of its hospice-related subsidiaries alleging that, since at least 2002, Vitas, and since 2004, the Company, submitted or caused the submission of false claims to the Medicare program by (a) billing Medicare for unnecessary crisis care services, and (b) admitting patients who were not eligible for the Medicare hospice benefit. The firm is investigating legal claims against the officers and Board of Directors of Chemed.
For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: email@example.com.Overhill Farms, Inc. Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Overhill Farms, Inc. ("Overhill Farms" or the "Company") (OFI) to Bellisio Foods, Inc. in a cash transaction valued at approximately $80.9 million or $5.00 per share in cash. Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to the Company's shareholders. For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: firstname.lastname@example.org. Theragenics Corporation Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the receipt of a proposal from Juniper Investment Company, LLC ("Juniper") to acquire all of the Theragenics Corporation ("Theragenics" or the "Company") (TGX) outstanding common stock for $2.25 to $2.30 per share in cash. The Company has entered into an agreement ("Letter Agreement") dated May 12, 2013 to deal and negotiate exclusively with Juniper through June 11, 2013 regarding a merger transaction. Lifshitz Law Firm's investigation is focused on whether the Board of Directors of the Company is acting in the Company's shareholders' best interests in connection with the sale process.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts